NO20010489L - Forhindring av migrenetilbakefall - Google Patents
Forhindring av migrenetilbakefallInfo
- Publication number
- NO20010489L NO20010489L NO20010489A NO20010489A NO20010489L NO 20010489 L NO20010489 L NO 20010489L NO 20010489 A NO20010489 A NO 20010489A NO 20010489 A NO20010489 A NO 20010489A NO 20010489 L NO20010489 L NO 20010489L
- Authority
- NO
- Norway
- Prior art keywords
- prevention
- relapse
- migraine
- migraine relapse
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9816556.6A GB9816556D0 (en) | 1998-07-30 | 1998-07-30 | Therapy |
| PCT/IB1999/001105 WO2000006161A1 (en) | 1998-07-30 | 1999-06-14 | Prevention of migraine recurrence |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20010489D0 NO20010489D0 (no) | 2001-01-29 |
| NO20010489L true NO20010489L (no) | 2001-03-26 |
Family
ID=10836395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20010489A NO20010489L (no) | 1998-07-30 | 2001-01-29 | Forhindring av migrenetilbakefall |
Country Status (36)
| Country | Link |
|---|---|
| EP (3) | EP1466601A3 (is) |
| JP (1) | JP3824863B2 (is) |
| KR (2) | KR100441732B1 (is) |
| CN (2) | CN1522697A (is) |
| AP (1) | AP1402A (is) |
| AT (1) | ATE261304T1 (is) |
| AU (1) | AU3952199A (is) |
| BG (1) | BG65309B1 (is) |
| BR (1) | BR9912588A (is) |
| CA (1) | CA2338901C (is) |
| CZ (1) | CZ2001357A3 (is) |
| DE (1) | DE69915486T2 (is) |
| DK (1) | DK1100499T3 (is) |
| EA (2) | EA200201149A1 (is) |
| EE (1) | EE04703B1 (is) |
| ES (1) | ES2214027T3 (is) |
| GB (1) | GB9816556D0 (is) |
| GE (2) | GEP20063719B (is) |
| HK (1) | HK1038198A1 (is) |
| HR (1) | HRP20010079A2 (is) |
| HU (1) | HUP0103424A3 (is) |
| ID (1) | ID26996A (is) |
| IL (1) | IL140169A0 (is) |
| IS (1) | IS2253B (is) |
| NO (1) | NO20010489L (is) |
| NZ (2) | NZ508736A (is) |
| OA (1) | OA11576A (is) |
| PL (1) | PL194611B1 (is) |
| PT (1) | PT1100499E (is) |
| SG (1) | SG125910A1 (is) |
| SK (1) | SK1182001A3 (is) |
| TR (1) | TR200100314T2 (is) |
| TW (2) | TW537893B (is) |
| UA (1) | UA76399C2 (is) |
| WO (1) | WO2000006161A1 (is) |
| YU (2) | YU6401A (is) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8022095B2 (en) | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
| GB9915231D0 (en) | 1999-06-29 | 1999-09-01 | Pfizer Ltd | Pharmaceutical complex |
| CN1176649C (zh) * | 2002-10-16 | 2004-11-24 | 上海医药工业研究院 | 舒马普坦干粉吸入剂及其制备方法 |
| AU2003303631B2 (en) * | 2002-12-26 | 2008-05-29 | Nuvo Pharmaceuticals (Ireland) Designated Activity Company | Multilayer Dosage Forms Containing NSAIDs and Triptans |
| WO2004089365A1 (en) | 2003-04-11 | 2004-10-21 | Pfizer Limited | Pharmaceutical combination comprising eletriptan and sodium bicarbonate |
| GB2407498B (en) * | 2003-10-30 | 2008-06-11 | Cipla Ltd | Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient |
| FR2926721B1 (fr) * | 2008-01-30 | 2011-07-22 | Philippe Perovitch | Forme galenique pour l'adminsitration par voie trans-muqueuse de triptans |
| AU2009260166B2 (en) | 2008-06-20 | 2014-10-09 | Alphapharm Pty Ltd | Pharmaceutical formulation |
| US8680134B2 (en) | 2009-10-23 | 2014-03-25 | Avi Dascalu | Triptans for the treatment of psoriasis |
| PL2838517T3 (pl) | 2012-04-18 | 2018-03-30 | Contera Pharma Aps | Przeznaczony do podawania doustnego preparat farmaceutyczny na potrzeby udoskonalonego leczenia zaburzeń ruchowych |
| CN103385876B (zh) * | 2012-05-08 | 2016-01-13 | 四川滇虹医药开发有限公司 | 一种夫罗曲坦的药物组合物及其制备方法 |
| CN104523709A (zh) * | 2014-12-22 | 2015-04-22 | 青岛正大海尔制药有限公司 | 一种含有琥珀酸夫罗曲坦的复方缓释制剂 |
| CN109689036A (zh) | 2016-07-11 | 2019-04-26 | 康特拉医药公司 | 用于治疗早晨运动不能的脉冲药物输送系统 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0592438B1 (en) * | 1990-10-15 | 1997-08-27 | Pfizer Inc. | Indole derivatives |
| EP0546593B1 (en) * | 1991-10-30 | 1997-09-03 | Glaxo Group Limited | Multi-layered compositions containing histamine or serotonin antagonists |
| US5464633A (en) * | 1994-05-24 | 1995-11-07 | Jagotec Ag | Pharmaceutical tablets releasing the active substance after a definite period of time |
| GB9417310D0 (en) * | 1994-08-27 | 1994-10-19 | Pfizer Ltd | Therapeutic agents |
| US5698571A (en) * | 1994-10-05 | 1997-12-16 | Eli Lilly And Company | 5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine |
| US5744482A (en) * | 1994-10-05 | 1998-04-28 | Eli Lilly And Company | Serotonin agonist in combination with a tachykinin receptor antagonist in the treatment or prevention of migraine |
| IL127955A0 (en) * | 1996-07-11 | 1999-11-30 | Farmarc Nederland Bv | Pharmaceutical composition containing acid addition salt of basic drug |
| AU724728B2 (en) * | 1997-07-03 | 2000-09-28 | Pfizer Inc. | Pharmaceutical compositions containing eletriptan hemisulphate and caffeine |
| US6514530B2 (en) * | 1997-09-09 | 2003-02-04 | Alza Corporation | Dosage form comprising means for changing drug delivery shape |
-
1998
- 1998-07-30 GB GBGB9816556.6A patent/GB9816556D0/en not_active Ceased
-
1999
- 1999-06-14 OA OA1200000354A patent/OA11576A/en unknown
- 1999-06-14 CN CNA2003101025101A patent/CN1522697A/zh active Pending
- 1999-06-14 AP APAP/P/2001/002056A patent/AP1402A/en active
- 1999-06-14 CN CNB998087378A patent/CN1155379C/zh not_active Expired - Fee Related
- 1999-06-14 KR KR10-2001-7001231A patent/KR100441732B1/ko not_active IP Right Cessation
- 1999-06-14 HU HU0103424A patent/HUP0103424A3/hu unknown
- 1999-06-14 YU YU6401A patent/YU6401A/sh unknown
- 1999-06-14 PL PL99345803A patent/PL194611B1/pl not_active IP Right Cessation
- 1999-06-14 AT AT99922459T patent/ATE261304T1/de not_active IP Right Cessation
- 1999-06-14 KR KR10-2003-7008744A patent/KR20030078876A/ko not_active Application Discontinuation
- 1999-06-14 EP EP04004643A patent/EP1466601A3/en not_active Withdrawn
- 1999-06-14 EA EA200201149A patent/EA200201149A1/ru unknown
- 1999-06-14 AU AU39521/99A patent/AU3952199A/en not_active Abandoned
- 1999-06-14 CA CA002338901A patent/CA2338901C/en not_active Expired - Fee Related
- 1999-06-14 YU YU20303A patent/YU20303A/sh unknown
- 1999-06-14 ID IDW20010229A patent/ID26996A/id unknown
- 1999-06-14 CZ CZ2001357A patent/CZ2001357A3/cs unknown
- 1999-06-14 UA UA2001010653A patent/UA76399C2/uk unknown
- 1999-06-14 JP JP2000562016A patent/JP3824863B2/ja not_active Expired - Fee Related
- 1999-06-14 DE DE69915486T patent/DE69915486T2/de not_active Expired - Fee Related
- 1999-06-14 WO PCT/IB1999/001105 patent/WO2000006161A1/en active IP Right Grant
- 1999-06-14 IL IL14016999A patent/IL140169A0/xx unknown
- 1999-06-14 EP EP04004644A patent/EP1435237A1/en not_active Withdrawn
- 1999-06-14 EP EP99922459A patent/EP1100499B1/en not_active Expired - Lifetime
- 1999-06-14 TR TR2001/00314T patent/TR200100314T2/xx unknown
- 1999-06-14 BR BR9912588-9A patent/BR9912588A/pt not_active Application Discontinuation
- 1999-06-14 EA EA200100089A patent/EA004036B1/ru not_active IP Right Cessation
- 1999-06-14 SK SK118-2001A patent/SK1182001A3/sk unknown
- 1999-06-14 PT PT99922459T patent/PT1100499E/pt unknown
- 1999-06-14 SG SG200300769A patent/SG125910A1/en unknown
- 1999-06-14 NZ NZ508736A patent/NZ508736A/en unknown
- 1999-06-14 GE GEAP19996881A patent/GEP20063719B/en unknown
- 1999-06-14 EE EEP200100061A patent/EE04703B1/xx not_active IP Right Cessation
- 1999-06-14 ES ES99922459T patent/ES2214027T3/es not_active Expired - Lifetime
- 1999-06-14 GE GEAP19995732A patent/GEP20043157B/en unknown
- 1999-06-14 DK DK99922459T patent/DK1100499T3/da active
- 1999-06-17 TW TW088110233A patent/TW537893B/zh not_active IP Right Cessation
- 1999-06-17 TW TW092102563A patent/TWI248362B/zh not_active IP Right Cessation
-
2000
- 2000-12-15 IS IS5771A patent/IS2253B/is unknown
-
2001
- 2001-01-29 NO NO20010489A patent/NO20010489L/no not_active Application Discontinuation
- 2001-01-30 HR HR20010079A patent/HRP20010079A2/hr not_active Application Discontinuation
- 2001-02-20 BG BG105277A patent/BG65309B1/bg unknown
- 2001-12-27 HK HK01109100A patent/HK1038198A1/xx not_active IP Right Cessation
-
2003
- 2003-08-15 NZ NZ527625A patent/NZ527625A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS5574A (is) | Útskiptir Xa-þáttar oxóasaheterósýklýl-tálmar | |
| NO20003486D0 (no) | Belegg av polymerer | |
| FI980732A0 (fi) | Foerfarande foer koppling av dataoeverfoeringsstroemmar | |
| FI980343A0 (fi) | Foerfarande foer kontrollering av effekt | |
| ID27092A (id) | Pembuatan ftalat anhidrida | |
| NO20010899D0 (no) | Forbedring av ugunstige apomorfin-effekter | |
| IT1295008B1 (it) | Combinazione di stabilizzanti | |
| FI980783A0 (fi) | Foerfarande foer utformning av en signaleringsfoerbindelse | |
| NO994790L (no) | Estimering av permabilitet | |
| NO20010489D0 (no) | Forhindring av migrenetilbakefall | |
| FI980327A0 (fi) | Foerfarande foer foermedling av telefonsamtal | |
| ID28032A (id) | TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2 | |
| NO991115D0 (no) | Belegging av mineralholdige st°peartikler | |
| NO20006262D0 (no) | Fôring av rör | |
| ATA146797A (de) | Schallschutzwand | |
| NO20012276L (no) | Identifisering av SENV-genotyper | |
| FI19991831A (fi) | Eristysmateriaalien pinnoite | |
| NO20021260D0 (no) | Estimering av amplityde-spektra | |
| NO20003529D0 (no) | Behandling av dyskinesi | |
| FI980710A0 (fi) | Foerfarande foer smaeltning av stenmaterial foer mineralullsproduktion | |
| NO980820D0 (no) | Dusjhode | |
| NO20011268D0 (no) | Forbindelse til behandling av depresjon | |
| SE9801284D0 (sv) | Installation av spishäll | |
| NO994020D0 (no) | Kansellering av interferens | |
| FI980285A0 (fi) | Anordning foer kantning av braedor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |